Aptose Biosciences Inc [APTO] stock is trading at $0.19, up 0.70%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The APTO shares have gain 5.62% over the last week, with a monthly amount drifted -52.74%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Aptose Biosciences Inc [NASDAQ: APTO] stock has seen the most recent analyst activity on October 19, 2020, when Cantor Fitzgerald initiated its Overweight rating and assigned the stock a price target of $10. Previously, Alliance Global Partners started tracking the stock with Buy rating on September 22, 2020, and set its price target to $12. On February 20, 2020, Maxim Group initiated with a Buy rating and assigned a price target of $16 on the stock. H.C. Wainwright reiterated its Buy rating and increased its price target to $9 on February 06, 2020. Piper Sandler initiated its recommendation with a Overweight and recommended $10 as its price target on January 09, 2020. RBC Capital Mkts started tracking with a Outperform rating for this stock on March 01, 2019, and assigned it a price target of $6. In a note dated November 16, 2018, B. Riley FBR initiated an Buy rating and provided a target price of $5 on this stock.
Aptose Biosciences Inc [APTO] stock has fluctuated between $0.13 and $2.91 over the past year. Aptose Biosciences Inc [NASDAQ: APTO] shares were valued at $0.19 at the most recent close of the market.
Analyzing the APTO fundamentals
Gross Profit Margin for this corporation currently stands at 0.52% with Operating Profit Margin at -51.23%, Pretax Profit Margin comes in at -50.67%, and Net Profit Margin reading is -50.67%. To continue investigating profitability, this company’s Return on Assets is posted at -3.3, Equity is 10.27 and Total Capital is -31.16. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -1.09.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.1832 points at the first support level, and at 0.1783 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.1964, and for the 2nd resistance point, it is at 0.2047.
Ratios To Look Out For
For context, Aptose Biosciences Inc’s Current Ratio is 1.05. In addition, the Quick Ratio stands at 1.05.
Transactions by insiders
Recent insider trading involved Rice William G., Chair, President & CEO, that happened on Nov 25 ’24 when 100000.0 shares were purchased.
